Magnitude Biosciences
Operator of a patented in vivo testing platform designed to accelerate drug and product development through rapid, cost-effective data generation using C. elegans. The company offers high-throughput, ...
Valuation
$3.6M
Market implied
Share Price
N/A
Total Raised
$2.9M
Last Round
N/A